The therapeutic galcanezumab, initially known as LY2951742, represents the critical step in migraine management. Its chemical structure is that of the humanized monoclonal protein, specifically targeting CGRP target. This complex molecule comprises large and minor chains, linked by disulfide bond

Emicizumab, referred to as ART-101 is signifying a crucial development in treating these genetic disorder. This groundbreaking therapy functions as a prothrombin activator , mimicking factor VIII, a element often missing in people with this condition. Unlike existing factor replacement , emicizum

The appearance of troglitazone, a potent antidiabetic agent, marked a significant chapter in the management of type 2 diabetes. However, its removal from the market due to serious hepatotoxicity spurred broad investigation into related thiazolidinediones. Subsequently pioglitazone and rosiglitazo